| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,473 |
5,447 |
$274K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,934 |
4,547 |
$157K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
990 |
777 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
1,775 |
1,553 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
447 |
394 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
370 |
155 |
$3K |
| 99215 |
Prolong outpt/office vis |
62 |
54 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
44 |
38 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
25 |
24 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
29 |
29 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
49 |
43 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
16 |
15 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15 |
13 |
$741.88 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
12 |
12 |
$530.46 |
| 99406 |
|
78 |
68 |
$493.58 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
66 |
56 |
$419.61 |
| 99072 |
|
838 |
583 |
$351.33 |
| 90686 |
|
14 |
12 |
$148.55 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
5,165 |
3,180 |
$13.69 |
| 1036F |
|
448 |
278 |
$0.20 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
1,715 |
1,113 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,462 |
1,053 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
980 |
787 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
1,665 |
1,085 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
43 |
39 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
257 |
187 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,755 |
2,017 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,254 |
920 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
427 |
346 |
$0.00 |
| 888888 |
|
216 |
174 |
$0.00 |